Neuphoria Therapeutics, Inc. (NASDAQ: NEUP) related to its merger with Scancell Holdings plc. Upon completion of the proposed transaction, Neuphoria stockholders are expected to own 11.1% of the combined company.
Neuphoria Therapeutics, Inc. (NASDAQ: NEUP) related to its merger with Scancell Holdings plc. Upon completion of the proposed transaction, Neuphoria stockholders are expected to own 11.1% of the combined company.